La catena delle opzioni mostra i dati chiave delle opzioni azionarie di X4 Pharmaceuticals a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per X4 Pharmaceuticals..

X4 Pharmaceuticals (NASDAQ:XFOR) Azioni, Quote.MetaTitle.option-chain

X4 Pharmaceuticals

Panoramica

Notizie

Utili

Opzioni

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

Comments

X4 Pharmaceuticals Catena di Opzioni

Opzioni

X4 Pharmaceuticals (NASDAQ:XFOR) Azioni, Quote.MetaTitle.option-chain

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO